Email this article A case of Becker myotonia with pseudodominant inheritance: сurrent approaches to the differential diagnosis of Thomsen’s and Becker's myotonia congenita
- Authors: Kurbatov S.A.1,2,3, Nikitin S.S.4,5,3, Illarioshkin S.N.6,7,3, Gundorova P.8,9, Polyakov A.V.8,9
-
Affiliations:
- Voronezh Medical Genetic Consulting and Diagnostic Center
- 5А square Lenina, Voronezh, 394018, Russia
- Medical Center “Practical Neurology”, Society of Neuromuscular Disease Specialists
- Build. 2, 17 Krzhizhanovsky St., Moscow, 117218, Russia
- Neurology Research Center
- 80 Volokolamskoe Shosse, Moscow, 125367, Russia
- Research Center of Medical Genetics
- 1 Moskvorech’e St., Moscow, 115522, Russia
- Issue: Vol 6, No 1 (2016)
- Pages: 74-81
- Section: CLINICAL DISCUSSION
- Published: 29.03.2016
- URL: https://nmb.abvpress.ru/jour/article/view/140
- DOI: https://doi.org/10.17650/2222-8721-2016-6-1-74-81
- ID: 140
Cite item
Full Text
Abstract
Myotonia congenital (MC) is the most common form of the hereditary nondystrophic myotonias caused by mutations in the skeletal muscle chloride channel gene (CLCN1) which change the functional features of muscle fibers membrane. MC is represented by two allelic forms with different types of inheritance: Thomsen’s myotonia congenita (TMC) with an autosomal dominant and Becker’s myotonia congenita (BMC) with an autosomal recessive inheritance. Both forms, TMC and BMC have the same clinical manifestation: skeletal muscle hypertrophy, transient weakness, generalized myotonia, debut in early childhood and a stationary development. Diseases are characterized by equal neurophysiological changes. In the family usually only one patient is detected. In some cases with the horizontal segregation diseases, more than one mutation in CLCN1 gene is found. These factors complicate the diagnosis of TMC and BMC, further medical and genetic counseling of the family members even after the patient’s genotype is detected. The confirmed BMC case with pseudo dominant type of inheritance and limited clinical manifestation is discussed in the light of differential diagnosis of the two discussed diseases.
About the authors
S. A. Kurbatov
Voronezh Medical Genetic Consulting and Diagnostic Center; 5А square Lenina, Voronezh, 394018, Russia;
Author for correspondence.
Email: kurbatov80@gmail.com
Russian Federation
S. S. Nikitin
Medical Center “Practical Neurology”, Society of Neuromuscular Disease Specialists; Build. 2, 17 Krzhizhanovsky St., Moscow, 117218, Russia;
Email: fake@neicon.ru
Russian Federation
S. N. Illarioshkin
Neurology Research Center; 80 Volokolamskoe Shosse, Moscow, 125367, Russia;
Email: fake@neicon.ru
Russian Federation
P. Gundorova
Research Center of Medical Genetics; 1 Moskvorech’e St., Moscow, 115522, Russia
Email: fake@neicon.ru
Russian Federation
A. V. Polyakov
Research Center of Medical Genetics; 1 Moskvorech’e St., Moscow, 115522, Russia
Email: fake@neicon.ru
Russian Federation
References
Supplementary files
